Diabetes

Early dementia, diabetes linked

By

Diabetics are at risk of developing dementia earlier and dying sooner, according to research in the American Journal of Epidemiology.

Investigators find wound healing 'switch'

By

Researchers recently identified a molecular "switch" mechanism that takes place during successful wound care healing. The discovery is likely to aid in the understanding of how wounds get better, and fuel preventive treatments.

Elderly left off diabetes trials

Far too few clinical trials are focused on seniors with diabetes, according to an analysis recently published in the journal Diabetologia. Researchers at the Duke University School of Medicine looked at about 2,500 diabetes-related trials that appeared on the ClinicalTrials.gov website between 2007 and 2010.

Diabetics develop dementia 2 years sooner than others, researchers find

By

People with diabetes are at risk of developing dementia earlier and dying sooner, according to recently published research.

New kind of diabetes drug gets OK

New kind of diabetes drug gets OK

The Food and Drug Administration recently approved a new kind of type 2 diabetes drug to help better control glucose levels. Invokana prevents the kidney from reabsorbing glucose, according to the FDA.

Diabetes research ignores older people, study finds

By

Far too few clinical trials are focused on seniors with diabetes, according to an analysis recently published in the journal Diabetologia.

FDA approves new kind of oral diabetes drug

By

The Food and Drug Administration recently approved a new kind of type 2 diabetes drug to help better control glucose levels.

Oxygen chambers don't help wounds in LTC setting: study

Oxygen chambers don't help wounds in LTC setting: study By

Long-term care providers might want to think twice about including oxygen exposure in the treatment regimen for residents with diabetic foot ulcers. Oxygen treatment does not improve wound healing and may actually be harmful, according to new findings by researchers at the University of Pennsylvania Perelman School of Medicine.

Diabetes drugs under scrutiny

Diabetes drugs under scrutiny By

Diabetes medications Januvia and Byetta significantly increase the risk of pancreatic inflammation, according to Johns Hopkins University School of Medicine researchers.

Diabetes drugs linked to pancreatitis have a possible cancer connection, FDA says

By

The Food and Drug Administration is investigating a possible link between commonly prescribed diabetes drugs and pancreatic cancer. The drugs, including Januvia and Byetta, were previously connected with fatal cases of pancreatic inflammation known as pancreatitis.

Vitamin D for dummies

Vitamin D for dummies By

It's not a secret that employees who work in healthcare, whether they are medical journalists or nurses, don't always earn gold stars when it comes to managing their own health. Witness the nurses clustering in a "butt hut" outside a facility, an administrator taking a cavalier approach to his or her diet, or saleswomen wearing sole-killing heels at a conference.

Diabetics on Januvia, Byetta at risk for dangerous pancreatic inflammation, researchers find

By

Johns Hopkins University School of Medicine researchers looked at 1,269 people who took at least one prescription diabetes drug between 2005-2008, comparing them to a control group of 1,269 diabetics who did not take a prescription drug to treat the condition during that period.

Researchers pave way for new treatment for serious wounds

By

A recent breakthrough could lead to more effective treatments for tenacious wounds such as diabetic foot ulcers, according to a report in the journal Nature Chemistry.

Quick treatment after transient ischemic attacks could prevent many strokes, researchers document

By

Seniors who suffer transient ischemic attacks, or mini-strokes, are at greatly heightened risk for experiencing a full-blown stroke soon after and should seek treatment quickly. That's according to recently published research from neurologists at Chicago's Loyola University Medical Center.

Some diabetics can eat right away after taking insulin

People with type 2 diabetes can eat immediately after injecting insulin without compromising their blood sugar level, according to a recently published study in the journal Diabetes Care.

AssuraMed buys Invacare's medical supplies business

Invacare Corporation has completed the sale of its medical supplies business to AssuraMed for about $150 million, the firm announced. Invacare will retain its equipment business, which includes wheelchairs and respiratory equipment.

Diabetes, high blood pressure linked to colon cancer recurrence

A new study shows that patients with early stage colon cancer who also have diabetes or high blood pressure (both components of metabolic syndrome) have a greater risk for a recurrence of the cancer and a higher mortality rate compared to colon cancer patients without the diseases.

GSK will pay $90 million to settle diabetes drug allegations

GlaxoSmithKline will pay a $90 million settlement to 38 states that claimed it unlawfully promoted its diabetes treatment Avandia (rosiglitazone). As a result of the settlement, GSK must change the way it promotes its diabetes drugs, including Avandia.

Diabetic patients need early testing for hearing impairment, study shows

By

Patients with diabetes are more than twice as likely to have hearing impairment than individuals without, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

Type 2 diabetics more likely to develop UTIs, research finds

By

People with type 2 diabetes are more likely than non-diabetics to develop urinary tract infections, a British study recently found.

Clinical Clues to Undiagnosed Type 2 Diabetes in a 53-year-old Man - EXPIRED

Clinical Clues to Undiagnosed Type 2 Diabetes in a 53-year-old Man - EXPIRED

A 53-year-old man with type 2 diabetes presents to his internist with erectile dysfunction, increased appetite, and blurry vision. At his last visit 6 months ago, his LDL-C was borderline high.

Drug company to pay $3 billion to settle criminal charges

Drug company to pay $3 billion to settle criminal charges

In what is the biggest healthcare fraud settlement in U.S. history, drugmaker GlaxoSmithKline will pay $3 billion and plead guilty to illegally promoting prescription drugs.

Device may soon have providers breathing easier

Device may soon have providers breathing easier

Researchers are developing a breathalyzer that may soon be able to detect diabetes, lung cancer, viral infections and other maladies that often affect nursing home patients. Patients blow into a small valve attached to a box that is about half the size of a typical shoebox and weighs less than one pound. The device then seeks biomarkers for conditions and ailments. Funding for the project has been provided by the National Science Foundation.

Report sees growing role for mHealth tools

More than three million patients will be monitored by mobile networks by 2016, according to a Juniper Research report. The growth will be driving by higher demand for healthcare peripherals and greater processing power in smartphones, the investigation concludes. The cost of managing diabetes and other chronic conditions will decrease as a result, authors note.

Researchers discover women feel higher levels of pain

Women with chronic ailments experience more intense pain than men, according to a new study. Results and further research could eventually lead to more accurate pain-medication prescribing for both men and women, experts say.

FDA warns J & J on insulin pumps

Johnson & Johnson could face penalties for not reporting incidents where insulin pumps have failed, the Food and Drug Administration has warned.

Statins linked to diabetes risk in women, study finds

In a rare blow to positive news surrounding statins, a new study reveals the heart drugs are associated with a higher risk of diabetes in older women.

For diabetics, this news may bring tears of joy

Residents with diabetes may soon be able to use their tears — rather than have blood drawn up to10 times each day — when it's time to measure glucose levels. University of Michigan researchers using an electrochemical sensor device found that glucose levels from the tears may suffice. Many people are reluctant to have their blood drawn, because of the resulting inconvenience and pain. Investigators said they hope to eliminate the need to have blood drawn in the future.

Tear drop tests as effective as blood for diabetes testing, study finds

There is new hope for diabetics who dread frequent finger pricks and blood draws used to monitor their blood glucose levels. Scientists say they are developing a device that can test blood sugar levels via teardrops instead of blood.

Study: Depression associated with increased risk of stroke

People who suffer from depression have a 45% increased risk of stroke and a 55% higher risk of having a fatal stroke, according to a new study.

Featured Articles